Related Experiment Video
Updated: Mar 31, 2026

12:07
Three-dimensional Biomimetic Technology: Novel Biorubber Creates Defined Micro- and Macro-scale Architectures in Collagen Hydrogels
Published on: February 12, 2016
9.8K
Development and characterization of a rapid polymerizing collagen for soft tissue augmentation
Dale Devore1, Jiaxun Zhu1, Robert Brooks1
1EternoGen, LLC, 1601 South Providence, Columbia, Missouri, 65211.
Journal of Biomedical Materials Research. Part A
|October 22, 2015
Summary
A novel liquid collagen, Rapid Polymerizing Collagen (RPC), shows potential as a dermal filler. It effectively fibrillizes upon injection and demonstrates good biocompatibility for soft tissue augmentation.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Dermatology
Background:
- Soft tissue augmentation procedures often require injectable materials.
- Current fillers may have limitations in terms of injection ease, stability, and biocompatibility.
- Liquid collagen formulations that can fibrillize in situ are of significant interest.
Purpose of the Study:
- To synthesize and characterize Rapid Polymerizing Collagen (RPC), a type I porcine collagen, as a potential dermal filler.
- To evaluate the physicochemical properties and in vivo performance of RPC for soft tissue augmentation.
Main Methods:
- RPC was synthesized and characterized using techniques including transmission electron microscopy.
- Physicochemical properties were assessed via ion-induced fibrillogenesis tests and collagenase resistance assays.
- In vivo biocompatibility was evaluated through subcutaneous injections in miniature swine over 3 and 6 months.
Main Results:
- RPC demonstrated low injection force (<7 N) and rapid fibrillization upon contact with physiological solutions.
- The collagen exhibited enhanced resistance to collagenase breakdown.
- In vivo studies showed long-term biocompatibility with minimal irritation scores.
Conclusions:
- Rapid Polymerizing Collagen (RPC) possesses desirable properties for soft tissue augmentation, including injectability, in situ fibrillization, and good biocompatibility.
- RPC shows promise as a viable alternative to existing dermal fillers.
- Further research may explore its efficacy in various clinical applications.

